Determination of the role of serum alpha 1 anti-trypsin protein levels in oral squamous cell carcinoma Patients and in healthy snuff users and non-users
DOI:
https://doi.org/10.59736/IJP.23.04.1028Keywords:
Alpha 1 Antitrypsin, Oral Squamous Cell Carcinoma, TobaccoAbstract
Background: Among head & neck cancers, oral squamous cell carcinoma (OSCC) is the most common malignant neoplasm of lip and oral cavity. The serum analysis of different biomarkers including Alpha 1 antitrypsin, showed various biochemical changes which is considered to be significant in early intervention leading to an increase in survival rate. The objective of our study is to determine serum alpha 1 anti-trypsin (AAT) protein levels in oral squamous cell carcinoma patients and in healthy individuals (tobacco users and non-users) to detect the likelihood of OSCC development.
The rationale of the study is that the early detection of OSCC helps in early intervention which results in an increase in the survival rate.
Methods: This cross-sectional study was conducted from June 2023 to October 2023 at the Chemical Pathology Department of Mercy Teaching Hospital, Peshawar and the Department of Oral Pathology, Peshawar Dental College, Peshawar. A total of 90 subjects were included in the study, divided into 3 groups: 30 subjects having OSCC form Group A. Group B comprised of subjects who were healthy tobacco users. Group C comprised of subjects who were healthy and didn’t use tobacco. The evaluation of samples was carried out with alpha1antitrypsin ELISA kit and statistical analysis was performed using SPSS version 19.
Results: A slight rise regarding serum levels was seen for AAT antibody in Group B (healthy individuals tobacco users) (2.96) in comparison to Group C (healthy individuals’ tobacco non-users) (2.32). Also, AAT levels were expressed in serum of OSCC patients (2.53).
Conclusion: AAT may be used as a diagnostic marker for OSCC.
References
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–24.
Sahaf R, Naseem N, Anjum R, Nagi A. Oral squamous cell carcinoma: a clinicopathologic study. Pak Oral Dent J. 2017;37(1).
Mathur R, Singhavi HR, Malik A, Nair S, Chaturvedi P. Role of poor oral hygiene in causation of oral cancer: a review of literature. Indian J Surg Oncol. 2019; 10:184–95.
Markopoulos AK. Current aspects on oral squamous cell carcinoma. Open Dent J. 2012; 6:126–30.
Scully C, Bagan J. Oral squamous cell carcinoma overview. Oral Oncol. 2009;45(4–5):301–8.
Rivera C, Venegas B. Histological and molecular aspects of oral squamous cell carcinoma. Oncol Lett. 2014;8(1):7–11.
Kanwal M, Haider G, Zareef U, Saleem S. Addiction of tobacco chewing and smoking in patients with head and neck squamous cell carcinoma: a descriptive epidemiological study in Pakistan. Pak J Med Sci. 2019;35(6):1712–17.
Varshitha A. Prevalence of oral cancer in India. J Pharm Sci Res. 2015;7(10):845–48.
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.
Kawahara R, Bollinger JG, Rivera C, Ribeiro ACP, Brandão TB, Leme AFP, et al. A targeted proteomic strategy for the measurement of oral cancer candidate biomarkers in human saliva. Proteomics. 2016;16(1):159–73.
Iqbal F, Ahmad S, Maryam H, Amin H. Evidence of mutations in tumour suppressor genes among oral cancer in naswar smokeless tobacco users. Acta Odontol Scand. 2025;84(4):299–309.
Keshani F, Khalesi S, Aghaz A, Farhang M, Akbari N. Screening of oral squamous cell carcinoma by serum changes: a systematic review and meta-analysis. Dent Res J (Isfahan). 2021;18:
Bottomley SP. The folding pathway of α1-antitrypsin: avoiding the unavoidable. Proc Am Thorac Soc. 2010;7(6):404–7.
Ahuja US, Puri N, Bagewadi A, Keluskar V, Ahuja A, Singh HP. Comparative evaluation of serum alpha-1antitrypsin levels in patients with oral squamous cell carcinoma and in subjects with tobacco habit without carcinoma. J Family Med Prim Care. 2019 Nov 15;8(11):3657-63. doi: 10.4103/jfmpc.jfmpc_571_19.
Sharma B, Jain R. Right choice of a method for determination of cut-off values: a statistical tool for a diagnostic test. Asian J Med Sci. 2014;5(3):30–34.
Mahmood N, Hanif M, Ahmed A, Jamal Q, Khan A. Impact of age at diagnosis on clinicopathological outcomes of oral squamous cell carcinoma patients. Pak J Med Sci. 2018;34(3):595–99.
Asio J, Kamulegeya A, Banura C. Survival and associated factors among patients with oral squamous cell carcinoma in Mulago Hospital, Kampala, Uganda. Cancers Head Neck. 2018; 3:1–10.
Iamaroon A, Pattanaporn K, Pongsiriwet S, Wanachantararak S, Prapayasatok S, Jittidecharaks S, et al. Analysis of 587 cases of oral squamous cell carcinoma in northern Thailand with a focus on young people. Int J Oral Maxillofac Surg. 2004;33(1):84–88.
Paz AR, Cavalcanti YW, Godoy GP, Alves PM. Clinical findings and risk factors to oral squamous cell carcinoma in young patients: a 12-year retrospective analysis. Med Oral Patol Oral Cir Bucal. 2016;21(2): e151–e158.
Tandon P, Dadhich A, Saluja H, Bawane S, Sachdeva S. The prevalence of squamous cell carcinoma in different sites of the oral cavity at a rural health care centre in Loni, Maharashtra: a retrospective 10-year study. Contemp Oncol (Pozn). 2017;21(2):178–83.
Melo BAdC, Vilar LG, Oliveira NRd, Lima POd, Pinheiro MdB, Domingueti CP, et al. Human papillomavirus infection and oral squamous cell carcinoma: a systematic review. Braz J Otorhinolaryngol. 2021; 87:346–52.
Wolfer S, Kunzler A, Foos T, Ernst C, Leha A, Schultze-Mosgau S. Gender and risk-taking behaviors influence the clinical presentation of oral squamous cell carcinoma. Clin Exp Dent Res. 2022;8(1):141–51.
Babu C, Pereira T, Shetty S, Shrikant GS, Anjali A, Vidhale RG. Epidemiological trends of oral squamous cell carcinoma: an institutional study. Muller J Med Sci Res. 2021; 12:1–6.
Yasin MM, Abbas Z, Hafeez A. Correlation of histopathological patterns of oral squamous cell carcinoma patients with tumor site and habits. BMC Oral Health. 2022;22(1):1–7.
Wong YL, Anand R, Yuen KM, Mustafa WMW, Abraham MT, Tay KK, et al. Identification of potential glycoprotein biomarkers in oral squamous cell carcinoma using sweet strategies. Glycoconj J. 2021; 38:1–11.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Faizan Tariq, Fatima Iqbal, Tehmina Nausheen, Hayatullah Khan, Ambreen Gul, Abbas Saleem Khan
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Readers may “Share-copy and redistribute the material in any medium or format” and “Adapt-remix, transform, and build upon the material”. The readers must give appropriate credit to the source of the material and indicate if changes were made to the material. Readers may not use the material for commercial purpose. The readers may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
